Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...
Stocktwits on MSN
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs
Gilead will advance the clinical development and commercialization of the programs and Assembly Bio will receive a $35 ...
Zacks Investment Research on MSN
GILD exercises option to license Assembly Bio's herpes programs
Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences ...
Genital herpes is one of the most common sexually transmitted diseases in the U.S. It is caused by the herpes simplex virus (HSV). Most cases of genital herpes are caused by infection by the herpes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback